Literature DB >> 6183071

Relation of substance P to pain transmission: neurophysiological evidence.

J L Henry.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6183071     DOI: 10.1002/9780470720738.ch12

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


× No keyword cloud information.
  6 in total

1.  Sufentanil, morphine, met-enkephalin, and kappa-agonist (U-50,488H) inhibit substance P release from primary sensory neurons: a model for presynaptic spinal opioid actions.

Authors:  H M Chang; C B Berde; G G Holz; G F Steward; R M Kream
Journal:  Anesthesiology       Date:  1989-04       Impact factor: 7.892

2.  NK-1 receptor immunoreactivity in distinct morphological types of lamina I neurons of the primate spinal cord.

Authors:  X H Yu; E T Zhang; A D Craig; R Shigemoto; A Ribeiro-da-Silva; Y De Koninck
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

3.  Reduced substance P-like immunoreactivity in hereditary sensory neuropathy of pointer dogs.

Authors:  J F Cummings; A de Lahunta; S T Simpson; J M McDonald
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  Increased CCN2, substance P and tissue fibrosis are associated with sensorimotor declines in a rat model of repetitive overuse injury.

Authors:  Paul W Fisher; Yingjie Zhao; Mario C Rico; Vicky S Massicotte; Christine K Wade; Judith Litvin; Geoffrey M Bove; Steven N Popoff; Mary F Barbe
Journal:  J Cell Commun Signal       Date:  2015-01-24       Impact factor: 5.782

5.  Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin.

Authors:  R Laufer; U Wormser; Z Y Friedman; C Gilon; M Chorev; Z Selinger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

6.  Hyperalgesia produced by intrathecal substance P and related peptides: desensitization and cross desensitization.

Authors:  S M Moochhala; J Sawynok
Journal:  Br J Pharmacol       Date:  1984-06       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.